TreeWAS – Variant ID: rs145863439

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K83.1 Obstruction of bile duct	0.941	0.059	0.000
K83 Other diseases of biliary tract	0.933	0.067	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.888	0.112	0.000
K86 Other diseases of pancreas	0.887	0.113	0.000
K83.8 Other specified diseases of biliary tract	0.880	0.120	0.000
K86.1 Other chronic pancreatitis	0.873	0.127	0.000
K86.3 Pseudocyst of pancreas	0.835	0.165	0.000
K83.0 Cholangitis	0.781	0.219	0.000
K85 Acute pancreatitis	0.768	0.232	0.000
K86.8 Other specified diseases of pancreas	0.766	0.234	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.711	0.289	0.000
K83.5 Biliary cyst	0.669	0.331	0.000
K83.4 Spasm of sphincter of Oddi	0.669	0.331	0.000
K83.3 Fistula of bile duct	0.669	0.331	0.000
K83.2 Perforation of bile duct	0.669	0.331	0.000
K83.9 Disease of biliary tract, unspecified	0.642	0.358	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.637	0.363	0.000
K85.1 Biliary acute pancreatitis	0.632	0.368	0.000
K85.9 Acute pancreatitis, unspecified	0.631	0.369	0.000
K80 Cholelithiasis	0.582	0.418	0.000
K85.8 Other acute pancreatitis	0.551	0.449	0.000
K85.3 Drug-induced acute pancreatitis	0.551	0.449	0.000
K85.2 Alcohol-induced acute pancreatitis	0.551	0.449	0.000
K85.0 Idiopathic acute pancreatitis	0.551	0.449	0.000
K86.2 Cyst of pancreas	0.541	0.458	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.513	0.487	0.000
K80.2 Calculus of gallbladder without cholecystitis	0.492	0.508	0.000
K80.0 Calculus of gallbladder with acute cholecystitis	0.466	0.534	0.000
K87.1 Disorders of pancreas in diseases classified elsewhere	0.457	0.543	0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.457	0.543	0.000
K86.9 Disease of pancreas, unspecified	0.439	0.560	0.000
K80.3 Calculus of bile duct with cholangitis	0.417	0.582	0.000
K82 Other diseases of gallbladder	0.386	0.614	0.000
K81 Cholecystitis	0.318	0.682	0.000
K82.9 Disease of gallbladder, unspecified	0.304	0.696	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.299	0.700	0.000
K80.4 Calculus of bile duct with cholecystitis	0.284	0.716	0.000
K82.3 Fistula of gallbladder	0.277	0.723	0.000
K82.2 Perforation of gallbladder	0.277	0.723	0.000
K82.0 Obstruction of gallbladder	0.277	0.723	0.000
K80.8 Other cholelithiasis	0.270	0.730	0.000
K81.8 Other cholecystitis	0.240	0.760	0.000
K82.8 Other specified diseases of gallbladder	0.218	0.782	0.000
K82.4 Cholesterolosis of gallbladder	0.204	0.796	0.000
K82.1 Hydrops of gallbladder	0.200	0.799	0.000
K81.9 Cholecystitis, unspecified	0.194	0.806	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.191	0.809	0.000
K81.1 Chronic cholecystitis	0.148	0.852	0.000
K81.0 Acute cholecystitis	0.136	0.864	0.000
T39.1 4-Aminophenol derivatives	0.026	0.974	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.024	0.976	0.000
H35.8 Other specified retinal disorders	0.000	0.977	0.023
H35 Other retinal disorders	0.000	0.977	0.023
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.022	0.978	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.022	0.978	0.000
T40.2 Other opioids	0.022	0.978	0.000
C44.6 Skin of upper limb, including shoulder	0.022	0.978	0.000
H34 Retinal vascular occlusions	0.000	0.979	0.021
H30-H36 Disorders of choroid and retina	0.000	0.979	0.021
H34.8 Other retinal vascular occlusions	0.000	0.979	0.021
H33.3 Retinal breaks without detachment	0.000	0.979	0.021
T39.0 Salicylates	0.021	0.979	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.979	0.021
H33 Retinal detachments and breaks	0.000	0.979	0.021
H35.6 Retinal haemorrhage	0.000	0.980	0.020
T40.4 Other synthetic narcotics	0.019	0.980	0.000
H35.4 Peripheral retinal degeneration	0.000	0.981	0.019
H35.7 Separation of retinal layers	0.000	0.981	0.019
G40.9 Epilepsy, unspecified	0.019	0.981	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.018	0.981	0.000
H34.2 Other retinal artery occlusions	0.000	0.982	0.018
T46 Poisoning by agents primarily affecting the cardiovascular system	0.018	0.982	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.017	0.982	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.017	0.982	0.000
T39.4 Antirheumatics, not elsewhere classified	0.017	0.982	0.000
T39.2 Pyrazolone derivatives	0.017	0.982	0.000
T36 Poisoning by systemic antibiotics	0.017	0.983	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.017	0.983	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.017	0.983	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.017	0.983	0.000
H35.1 Retinopathy of prematurity	0.000	0.983	0.016
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.016	0.984	0.000
T40.8 Lysergide [LSD]	0.016	0.984	0.000
T40.7 Cannabis (derivatives)	0.016	0.984	0.000
T40.5 Cocaine	0.016	0.984	0.000
T40.3 Methadone	0.016	0.984	0.000
T40.1 Heroin	0.016	0.984	0.000
T40.0 Opium	0.016	0.984	0.000
H31 Other disorders of choroid	0.000	0.984	0.016
H33.5 Other retinal detachments	0.000	0.984	0.016
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.016	0.984	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.984	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.016	0.984	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.016	0.984	0.000
E10.9 Without complications	0.016	0.984	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.016	0.984	0.000
H33.2 Serous retinal detachment	0.000	0.984	0.016
Z91.5 Personal history of self-harm	0.016	0.984	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.016	0.984	0.000
H34.9 Retinal vascular occlusion, unspecified	0.000	0.984	0.015
H34.1 Central retinal artery occlusion	0.000	0.984	0.015
H34.0 Transient retinal artery occlusion	0.000	0.984	0.015
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.984	0.016
H30 Chorioretinal inflammation	0.000	0.984	0.016
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.015	0.985	0.000
T40.6 Other and unspecified narcotics	0.015	0.985	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.015	0.985	0.000
H35.9 Retinal disorder, unspecified	0.000	0.985	0.015
T46.3 Coronary vasodilators, not elsewhere classified	0.014	0.985	0.000
H33.0 Retinal detachment with retinal break	0.000	0.986	0.014
H33.4 Traction detachment of retina	0.000	0.986	0.014
H35.2 Other proliferative retinopathy	0.000	0.986	0.014
T42.4 Benzodiazepines	0.014	0.986	0.000
H35.5 Hereditary retinal dystrophy	0.000	0.986	0.014
T36.0 Penicillins	0.014	0.986	0.000
T45.0 Antiallergic and antiemetic drugs	0.014	0.986	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.013	0.986	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.013	0.986	0.000
T47.7 Emetics	0.013	0.986	0.000
T47.6 Antidiarrhoeal drugs	0.013	0.986	0.000
T47.5 Digestants	0.013	0.986	0.000
T47.4 Other laxatives	0.013	0.986	0.000
T47.3 Saline and osmotic laxatives	0.013	0.986	0.000
T47.2 Stimulant laxatives	0.013	0.986	0.000
T47.0 Histamine H(2)-receptor antagonists	0.013	0.986	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.013	0.986	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.013	0.987	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.013	0.987	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.013	0.987	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.013	0.987	0.000
T46.7 Peripheral vasodilators	0.013	0.987	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.013	0.987	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.013	0.987	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.013	0.987	0.000
D03 Melanoma in situ	0.013	0.987	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.013	0.987	0.000
D03.5 Melanoma in situ of trunk	0.013	0.987	0.000
T36.9 Systemic antibiotic, unspecified	0.012	0.987	0.000
T36.8 Other systemic antibiotics	0.012	0.987	0.000
T36.7 Antifungal antibiotics, systemically used	0.012	0.987	0.000
T36.6 Rifamycins	0.012	0.987	0.000
T36.5 Aminoglycosides	0.012	0.987	0.000
T36.4 Tetracyclines	0.012	0.987	0.000
T36.3 Macrolides	0.012	0.987	0.000
T36.2 Chloramphenicol group	0.012	0.987	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.987	0.000
H31.0 Chorioretinal scars	0.000	0.987	0.012
T45.9 Primarily systemic and haematological agent, unspecified	0.012	0.987	0.000
T45.8 Other primarily systemic and haematological agents	0.012	0.987	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.012	0.987	0.000
T45.6 Fibrinolysis-affecting drugs	0.012	0.987	0.000
T45.4 Iron and its compounds	0.012	0.987	0.000
T45.3 Enzymes, not elsewhere classified	0.012	0.987	0.000
T45.2 Vitamins, not elsewhere classified	0.012	0.987	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.987	0.000
T50.8 Diagnostic agents	0.012	0.987	0.000
T50.7 Analeptics and opioid receptor antagonists	0.012	0.987	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.012	0.987	0.000
T50.5 Appetite depressants	0.012	0.987	0.000
T50.4 Drugs affecting uric acid metabolism	0.012	0.987	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.012	0.987	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.012	0.987	0.000
T50.1 Loop [high-ceiling] diuretics	0.012	0.987	0.000
T50.0 Mineralocorticoids and their antagonists	0.012	0.987	0.000
T45.5 Anticoagulants	0.012	0.988	0.000
T38.9 Other and unspecified hormone antagonists	0.012	0.988	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.012	0.988	0.000
T38.7 Androgens and anabolic congeners	0.012	0.988	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.012	0.988	0.000
T38.5 Other oestrogens and progestogens	0.012	0.988	0.000
T38.4 Oral contraceptives	0.012	0.988	0.000
T38.2 Antithyroid drugs	0.012	0.988	0.000
T38.1 Thyroid hormones and substitutes	0.012	0.988	0.000
T38.0 Glucocorticoids and synthetic analogues	0.012	0.988	0.000
T46.1 Calcium-channel blockers	0.012	0.988	0.000
C54.1 Endometrium	0.012	0.988	0.000
H31.9 Disorder of choroid, unspecified	0.000	0.988	0.012
H31.8 Other specified disorders of choroid	0.000	0.988	0.012
H31.4 Choroidal detachment	0.000	0.988	0.012
H31.3 Choroidal haemorrhage and rupture	0.000	0.988	0.012
H31.2 Hereditary choroidal dystrophy	0.000	0.988	0.012
H31.1 Choroidal degeneration	0.000	0.988	0.012
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.012	0.988	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.012	0.988	0.000
T37.5 Antiviral drugs	0.012	0.988	0.000
T37.4 Anthelminthics	0.012	0.988	0.000
T37.3 Other antiprotozoal drugs	0.012	0.988	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.012	0.988	0.000
T37.1 Antimycobacterial drugs	0.012	0.988	0.000
T37.0 Sulphonamides	0.012	0.988	0.000
T41.5 Therapeutic gases	0.012	0.988	0.000
T41.4 Anaesthetic, unspecified	0.012	0.988	0.000
T41.3 Local anaesthetics	0.012	0.988	0.000
T41.2 Other and unspecified general anaesthetics	0.012	0.988	0.000
T41.1 Intravenous anaesthetics	0.012	0.988	0.000
T41.0 Inhaled anaesthetics	0.012	0.988	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.988	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
T48.5 Anti-common-cold drugs	0.012	0.988	0.000
T48.4 Expectorants	0.012	0.988	0.000
T48.3 Antitussives	0.012	0.988	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.012	0.988	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.988	0.000
T48.0 Oxytocic drugs	0.012	0.988	0.000
T49.9 Topical agent, unspecified	0.012	0.988	0.000
T49.8 Other topical agents	0.012	0.988	0.000
T49.7 Dental drugs, topically applied	0.012	0.988	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
T49.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
T49.3 Emollients, demulcents and protectants	0.012	0.988	0.000
T49.2 Local astringents and local detergents	0.012	0.988	0.000
T49.1 Antipruritics	0.012	0.988	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.012	0.988	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.012	0.988	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.012	0.988	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T42.2 Succinimides and oxazolidinediones	0.012	0.988	0.000
T42.1 Iminostilbenes	0.012	0.988	0.000
T42.0 Hydantoin derivatives	0.012	0.988	0.000
H30.9 Chorioretinal inflammation, unspecified	0.000	0.988	0.011
H30.8 Other chorioretinal inflammations	0.000	0.988	0.011
H30.2 Posterior cyclitis	0.000	0.988	0.011
H30.1 Disseminated chorioretinal inflammation	0.000	0.988	0.011
H30.0 Focal chorioretinal inflammation	0.000	0.988	0.011
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.000	0.988	0.011
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.000	0.988	0.011
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.011	0.989	0.000
D00-D09 In situ neoplasms	0.011	0.989	0.000
D03.4 Melanoma in situ of scalp and neck	0.011	0.989	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.011	0.989	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.989	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.989	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.989	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.989	0.000
T44.0 Anticholinesterase agents	0.011	0.989	0.000
D07.1 Vulva	0.011	0.989	0.000
C81.9 Hodgkin's disease, unspecified	0.011	0.989	0.000
C54 Malignant neoplasm of corpus uteri	0.011	0.989	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.011	0.989	0.000
H33.1 Retinoschisis and retinal cysts	0.000	0.989	0.011
C81 Hodgkin's disease	0.011	0.989	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.011	0.989	0.000
Chapter II Neoplasms	0.011	0.989	0.000
D48.7 Other specified sites	0.010	0.990	0.000
H36 Retinal disorders in diseases classified elsewhere	0.000	0.990	0.010
C43 Malignant melanoma of skin	0.010	0.990	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.010	0.990	0.000
C67 Malignant neoplasm of bladder	0.010	0.990	0.000
C51-C58 Malignant neoplasms of female genital organs	0.010	0.990	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.010	0.990	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.010	0.990	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.010	0.990	0.000
C64-C68 Malignant neoplasms of urinary tract	0.010	0.990	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.010	0.990	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.010	0.990	0.000
C81.1 Nodular sclerosis	0.010	0.990	0.000
D03.9 Melanoma in situ, unspecified	0.009	0.990	0.000
D03.8 Melanoma in situ of other sites	0.009	0.990	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.009	0.990	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.009	0.990	0.000
D03.0 Melanoma in situ of lip	0.009	0.990	0.000
E10 Insulin-dependent diabetes mellitus	0.009	0.991	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.009	0.991	0.000
D07.2 Vagina	0.009	0.991	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.009	0.991	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.009	0.991	0.000
C67.8 Overlapping lesion of bladder	0.009	0.991	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.009	0.991	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.009	0.991	0.000
C54.9 Corpus uteri, unspecified	0.009	0.991	0.000
C67.6 Ureteric orifice	0.009	0.991	0.000
C43.5 Malignant melanoma of trunk	0.009	0.991	0.000
C43.4 Malignant melanoma of scalp and neck	0.009	0.991	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.009	0.991	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.991	0.009
H66.3 Other chronic suppurative otitis media	0.009	0.991	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.009	0.991	0.000
Z88.1 Personal history of allergy to other antibiotic agents	0.009	0.991	0.000
D48.5 Skin	0.009	0.991	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.009	0.991	0.000
D04 Carcinoma in situ of skin	0.009	0.991	0.000
G40 Epilepsy	0.009	0.991	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.008	0.991	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.008	0.991	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.008	0.992	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.008	0.992	0.000
C43.9 Malignant melanoma of skin, unspecified	0.008	0.992	0.000
C66 Malignant neoplasm of ureter	0.008	0.992	0.000
T43.9 Psychotropic drug, unspecified	0.008	0.992	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.992	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.008	0.992	0.000
C67.4 Posterior wall of bladder	0.008	0.992	0.000
C67.3 Anterior wall of bladder	0.008	0.992	0.000
C54.8 Overlapping lesion of corpus uteri	0.008	0.992	0.000
C54.3 Fundus uteri	0.008	0.992	0.000
C54.2 Myometrium	0.008	0.992	0.000
C54.0 Isthmus uteri	0.008	0.992	0.000
D07.6 Other and unspecified male genital organs	0.008	0.992	0.000
D07.4 Penis	0.008	0.992	0.000
D07.3 Other and unspecified female genital organs	0.008	0.992	0.000
D07.0 Endometrium	0.008	0.992	0.000
Z36.8 Other antenatal screening	0.000	0.992	0.008
C81.7 Other Hodgkin's disease	0.008	0.992	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.008	0.992	0.000
C81.3 Lymphocytic depletion	0.008	0.992	0.000
C81.2 Mixed cellularity	0.008	0.992	0.000
C81.0 Lymphocytic predominance	0.008	0.992	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.008	0.992	0.000
D09 Carcinoma in situ of other and unspecified sites	0.008	0.992	0.000
E10.6 With other specified complications	0.008	0.992	0.000
C67.0 Trigone of bladder	0.008	0.992	0.000
C45 Mesothelioma	0.008	0.992	0.000
D37.7 Other digestive organs	0.008	0.992	0.000
E10.4 With neurological complications	0.008	0.992	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.008	0.992	0.000
D00.0 Lip, oral cavity and pharynx	0.008	0.992	0.000
C95 Leukaemia of unspecified cell type	0.008	0.992	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.008	0.992	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.008	0.992	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.008	0.992	0.000
C15-C26 Malignant neoplasms of digestive organs	0.008	0.992	0.000
D37.1 Stomach	0.008	0.992	0.000
Z36 Antenatal screening	0.000	0.992	0.008
T43.2 Other and unspecified antidepressants	0.007	0.992	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.007	0.992	0.000
D37.2 Small intestine	0.007	0.992	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.000	0.992	0.007
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.007	0.992	0.000
C94 Other leukaemias of specified cell type	0.007	0.992	0.000
C93 Monocytic leukaemia	0.007	0.992	0.000
C86 Other specified types of T/NK-cell lymphoma	0.007	0.992	0.000
C43.8 Overlapping malignant melanoma of skin	0.007	0.992	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.007	0.992	0.000
C43.0 Malignant melanoma of lip	0.007	0.992	0.000
C69 Malignant neoplasm of eye and adnexa	0.007	0.992	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.007	0.993	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.007	0.993	0.000
C67.7 Urachus	0.007	0.993	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.007	0.993	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.007	0.993	0.000
C85.1 B-cell lymphoma, unspecified	0.007	0.993	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.007	0.993	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.007	0.993	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.007	0.993	0.000
C58 Malignant neoplasm of placenta	0.007	0.993	0.000
C52 Malignant neoplasm of vagina	0.007	0.993	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.007	0.993	0.000
D48.6 Breast	0.007	0.993	0.000
D48.4 Peritoneum	0.007	0.993	0.000
D48.3 Retroperitoneum	0.007	0.993	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.007	0.993	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.007	0.993	0.000
H66 Suppurative and unspecified otitis media	0.007	0.993	0.000
C67.5 Bladder neck	0.007	0.993	0.000
E10.3 With ophthalmic complications	0.007	0.993	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.007	0.993	0.000
E10.8 With unspecified complications	0.007	0.993	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.007	0.993	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.007	0.993	0.000
D02.0 Larynx	0.007	0.993	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.007	0.993	0.000
C67.1 Dome of bladder	0.007	0.993	0.000
D04.4 Skin of scalp and neck	0.007	0.993	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.007	0.993	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.007	0.993	0.000
E10.7 With multiple complications	0.007	0.993	0.000
E10.0 With coma	0.007	0.993	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.007	0.993	0.000
C46 Kaposi's sarcoma	0.007	0.993	0.000
E10.2 With renal complications	0.007	0.993	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.007	0.993	0.000
C85.0 Lymphosarcoma	0.007	0.993	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.007	0.993	0.000
D00.2 Stomach	0.007	0.993	0.000
D00.1 Oesophagus	0.007	0.993	0.000
C50-C50 Malignant neoplasm of breast	0.007	0.993	0.000
D48.0 Bone and articular cartilage	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.007	0.993	0.000
C88 Malignant immunoproliferative diseases	0.007	0.993	0.000
D04.5 Skin of trunk	0.007	0.993	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.007	0.993	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.007	0.993	0.000
C25 Malignant neoplasm of pancreas	0.007	0.993	0.000
C51 Malignant neoplasm of vulva	0.007	0.993	0.000
D37.9 Digestive organ, unspecified	0.007	0.993	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.007	0.993	0.000
C67.2 Lateral wall of bladder	0.007	0.993	0.000
D37.0 Lip, oral cavity and pharynx	0.007	0.993	0.000
D02.4 Respiratory system, unspecified	0.007	0.993	0.000
D02.3 Other parts of respiratory system	0.007	0.993	0.000
D02.2 Bronchus and lung	0.007	0.993	0.000
D02.1 Trachea	0.007	0.993	0.000
F33 Recurrent depressive disorder	0.007	0.993	0.000
H65 Nonsuppurative otitis media	0.007	0.993	0.000
C49.3 Connective and soft tissue of thorax	0.007	0.993	0.000
C67.9 Bladder, unspecified	0.007	0.993	0.000
C91 Lymphoid leukaemia	0.007	0.993	0.000
C69.9 Eye, unspecified	0.007	0.993	0.000
C82.6 Cutaneous follicle centre lymphoma	0.006	0.993	0.000
C82.5 Diffuse follicle centre lymphoma	0.006	0.993	0.000
C82.4 Follicular lymphoma grade IIIb	0.006	0.993	0.000
C82.3 Follicular lymphoma grade IIIa	0.006	0.993	0.000
C82.2 Large cell, follicular	0.006	0.993	0.000
C82.0 Small cleaved cell, follicular	0.006	0.993	0.000
C45.9 Mesothelioma, unspecified	0.007	0.993	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.007	0.993	0.000
C07 Malignant neoplasm of parotid gland	0.006	0.993	0.000
C25.0 Head of pancreas	0.007	0.993	0.000
H35.3 Degeneration of macula and posterior pole	0.000	0.993	0.007
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.007	0.993	0.000
D46 Myelodysplastic syndromes	0.006	0.993	0.000
D04.6 Skin of upper limb, including shoulder	0.006	0.993	0.000
C80.9 Malignant neoplasm, unspecified	0.006	0.994	0.000
C80 Malignant neoplasm without specification of site	0.006	0.994	0.000
D04.9 Skin, unspecified	0.006	0.994	0.000
D04.8 Skin of other sites	0.006	0.994	0.000
D04.2 Skin of ear and external auricular canal	0.006	0.994	0.000
D04.1 Skin of eyelid, including canthus	0.006	0.994	0.000
D04.0 Skin of lip	0.006	0.994	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.006	0.994	0.000
G40.5 Special epileptic syndromes	0.006	0.994	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.006	0.994	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.006	0.994	0.000
C16 Malignant neoplasm of stomach	0.006	0.994	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.006	0.994	0.000
C60-C63 Malignant neoplasms of male genital organs	0.006	0.994	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.006	0.994	0.000
C70 Malignant neoplasm of meninges	0.006	0.994	0.000
D01.9 Digestive organ, unspecified	0.006	0.994	0.000
D01.7 Other specified digestive organs	0.006	0.994	0.000
D01.5 Liver, gallbladder and bile ducts	0.006	0.994	0.000
D01.4 Other and unspecified parts of intestine	0.006	0.994	0.000
D01.3 Anus and anal canal	0.006	0.994	0.000
D01.2 Rectum	0.006	0.994	0.000
D01.1 Rectosigmoid junction	0.006	0.994	0.000
D01.0 Colon	0.006	0.994	0.000
D37.3 Appendix	0.006	0.994	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.006	0.994	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.994	0.006
H65.2 Chronic serous otitis media	0.006	0.994	0.000
H65.3 Chronic mucoid otitis media	0.006	0.994	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.006	0.994	0.000
C45.0 Mesothelioma of pleura	0.006	0.994	0.000
C65 Malignant neoplasm of renal pelvis	0.006	0.994	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.006	0.994	0.000
D44.4 Craniopharyngeal duct	0.006	0.994	0.000
D44.3 Pituitary gland	0.006	0.994	0.000
D47.1 Chronic myeloproliferative disease	0.006	0.994	0.000
C17 Malignant neoplasm of small intestine	0.006	0.994	0.000
H65-H75 Diseases of middle ear and mastoid	0.006	0.994	0.000
C95.9 Leukaemia, unspecified	0.006	0.994	0.000
D37.6 Liver, gallbladder and bile ducts	0.006	0.994	0.000
C45.7 Mesothelioma of other sites	0.006	0.994	0.000
D09.9 Carcinoma in situ, unspecified	0.006	0.994	0.000
D09.7 Carcinoma in situ of other specified sites	0.006	0.994	0.000
D09.3 Thyroid and other endocrine glands	0.006	0.994	0.000
D09.2 Eye	0.006	0.994	0.000
D09.1 Other and unspecified urinary organs	0.006	0.994	0.000
C23 Malignant neoplasm of gallbladder	0.006	0.994	0.000
D04.3 Skin of other and unspecified parts of face	0.006	0.994	0.000
C21 Malignant neoplasm of anus and anal canal	0.006	0.994	0.000
D06 Carcinoma in situ of cervix uteri	0.005	0.994	0.001
C48.2 Peritoneum, unspecified	0.006	0.994	0.000
H66.4 Suppurative otitis media, unspecified	0.006	0.994	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.006	0.994	0.000
H73.8 Other specified disorders of tympanic membrane	0.006	0.994	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.006	0.994	0.000
C45.2 Mesothelioma of pericardium	0.006	0.994	0.000
C45.1 Mesothelioma of peritoneum	0.006	0.994	0.000
H73 Other disorders of tympanic membrane	0.006	0.994	0.000
C84.4 Peripheral T-cell lymphoma	0.006	0.994	0.000
F33.9 Recurrent depressive disorder, unspecified	0.006	0.994	0.000
G40.8 Other epilepsy	0.006	0.994	0.000
F30-F39 Mood [affective] disorders	0.006	0.994	0.000
D48.1 Connective and other soft tissue	0.006	0.994	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.006	0.994	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.006	0.994	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.006	0.994	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.006	0.994	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.994	0.006
C16.0 Cardia	0.006	0.994	0.000
C69.3 Choroid	0.006	0.994	0.000
C95.7 Other leukaemia of unspecified cell type	0.006	0.994	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.006	0.994	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.006	0.994	0.000
C95.0 Acute leukaemia of unspecified cell type	0.006	0.994	0.000
D44.9 Endocrine gland, unspecified	0.006	0.994	0.000
D44.8 Pluriglandular involvement	0.006	0.994	0.000
D44.7 Aortic body and other paraganglia	0.006	0.994	0.000
D44.6 Carotid body	0.006	0.994	0.000
D44.5 Pineal gland	0.006	0.994	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations